Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Neoplasms 1Liver Neoplasms 1Fibrosis 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Specimen Handling 124Capecitabine 124Temozolomide 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Enkephalin, Methionine × Clear all
NCT00783172 2018-09-06

Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer

Milton S. Hershey Medical Center

Phase 1 Terminated
4 enrolled
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT00706576 2017-08-02

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor

University of Missouri-Columbia

Phase 1 Completed
14 enrolled
Gastrointestinal

Fibrosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡